Michael E. Karellas, MD, FACS
Assistant Professor of UrologyCards
About
Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Michael Karellas, MD, is a urologic oncologist who treats urologic cancers, including bladder, kidney, prostate, and testicular cancer. He also treats general urology conditions such as kidney stones.
Dr. Karellas originally wanted to be a pharmacist but became interested in caring for patients in college. Then, in medical school, he found himself drawn to surgery. “In urology, I like that the nature of our surgery is generally curative,” he says.
Dr. Karellas recognizes the importance of working with patients to determine the best course of treatment for them. Most cancers have clinical guidelines based on standardized data to help determine which scientifically proven approach might best treat their cancer, he explains. “However, guidelines are not mandates, and I always discuss options with patients,” he says. “I listen to the patient to learn about their wishes, wants, and treatment goals. Then, I merge those with the standardized treatments to offer the best care possible for them.”
In addition to his clinical practice, Dr. Karellas is the director of the Western Division of Urology for Yale Medicine, an assistant professor of urology for Yale School of Medicine, and a researcher interested in a variety of urological treatments.
Clinical Specialties
Fact Sheets
Bladder Cancer
Learn More on Yale MedicineProstate Cancer
Learn More on Yale MedicineHolmium Laser Enucleation of the Prostate (HoLEP)
Learn More on Yale MedicineHereditary Breast and Ovarian Cancer Syndrome (HBOC)
Learn More on Yale Medicine
Board Certifications
Urology
- Certification Organization
- AB of Urology
- Latest Certification Date
- 2022
- Original Certification Date
- 2012
Yale Medicine News
News
News
- July 30, 2024
Yale Urology Welcomes New Faculty
- March 27, 2024
New Leadership and Long-term Plans at Yale Urology West
- January 12, 2024Source: Urology Times
AI and urologic oncology: An expert’s view
- November 27, 2023
Dr. Michael Karellas on Yale Cancer Answers